To characterize the cellular and molecular mechanisms of CD20-TCB-induced tumor cell killing, we analyzed the killing capacity of CD8+ T cells against two DLBCL cell lines: WSU DLCL2, and OCI-Ly18 (Fig 1a and S1a, S1b and S1f Fig). The gene discussed is CD8A; the disease is diffuse large B-cell lymphoma.